Trials / Completed
CompletedNCT02509897
Normobaric Hypoxic Training and Multiple Sclerosis
Cardiorespiratory, Metabolic and Immunoregulatory Response to Hypoxia in Multiple Sclerosis Patients: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To study the effects of normobaric hypoxic training on cardiorespiratory fitness, resting, postprandial and exercise activity energy expenditure, immunoregulatory functions and serum erythropoietin levels in relapsing-remitting multiple sclerosis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hypoxic training | Hypoxic training 3 times per week four four weeks |
| OTHER | Normoxic training | Normoxic training 3 times per week four four weeks |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-12-01
- Completion
- 2018-07-01
- First posted
- 2015-07-28
- Last updated
- 2022-07-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02509897. Inclusion in this directory is not an endorsement.